Dechra Pharmaceuticals Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 1/6
Dechra Pharmaceuticals şirketinin toplam hissedar öz sermayesi £755.2M ve toplam borcu £487.6M olup, bu da borç-öz sermaye oranını 64.6% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla £1.6B ve £814.2M dir. Dechra Pharmaceuticals 'in FAVÖK'ü £17.1M faiz karşılama oranı 0.8 dur. Şirketin £74.4M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.
Anahtar bilgiler
64.6%
Borç/özkaynak oranı
UK£487.60m
Borç
| Faiz karşılama oranı | 0.8x |
| Nakit | UK£74.40m |
| Eşitlik | UK£755.20m |
| Toplam yükümlülükler | UK£814.20m |
| Toplam varlıklar | UK£1.57b |
Son finansal sağlık güncellemeleri
Dechra Pharmaceuticals (LON:DPH) Takes On Some Risk With Its Use Of Debt
May 31
We Think Dechra Pharmaceuticals (LON:DPH) Is Taking Some Risk With Its Debt
Mar 02These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well
Jun 10Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly
Dec 04Recent updates
Dechra Pharmaceuticals (LON:DPH) Takes On Some Risk With Its Use Of Debt
May 31A Look At The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Mar 28We Think Dechra Pharmaceuticals (LON:DPH) Is Taking Some Risk With Its Debt
Mar 02Dechra Pharmaceuticals' (LON:DPH) Dividend Will Be Increased To £0.125
Mar 02Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Dec 09Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To £0.3289
Oct 06Dechra Pharmaceuticals (LON:DPH) Is Paying Out A Larger Dividend Than Last Year
Sep 22Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At £0.3289
Sep 08Estimating The Intrinsic Value Of Dechra Pharmaceuticals PLC (LON:DPH)
Aug 18Do Dechra Pharmaceuticals' (LON:DPH) Earnings Warrant Your Attention?
Aug 02These 4 Measures Indicate That Dechra Pharmaceuticals (LON:DPH) Is Using Debt Reasonably Well
Jun 10Calculating The Fair Value Of Dechra Pharmaceuticals PLC (LON:DPH)
May 08Do Dechra Pharmaceuticals's (LON:DPH) Earnings Warrant Your Attention?
Apr 22Dechra Pharmaceuticals (LON:DPH) Is Increasing Its Dividend To UK£0.12
Feb 23Is Dechra Pharmaceuticals PLC (LON:DPH) Expensive For A Reason? A Look At Its Intrinsic Value
Jan 29Is Now The Time To Put Dechra Pharmaceuticals (LON:DPH) On Your Watchlist?
Jan 11Here's Why Dechra Pharmaceuticals (LON:DPH) Can Manage Its Debt Responsibly
Dec 04It Looks Like Shareholders Would Probably Approve Dechra Pharmaceuticals PLC's (LON:DPH) CEO Compensation Package
Oct 15Dechra Pharmaceuticals' (LON:DPH) Upcoming Dividend Will Be Larger Than Last Year's
Sep 25Dechra Pharmaceuticals (LON:DPH) Will Pay A Larger Dividend Than Last Year At UK£0.29
Sep 11With EPS Growth And More, Dechra Pharmaceuticals (LON:DPH) Is Interesting
Sep 08Is Dechra Pharmaceuticals PLC (LON:DPH) Worth UK£43.4 Based On Its Intrinsic Value?
Jun 17Is Dechra Pharmaceuticals PLC (LON:DPH) A Smart Choice For Dividend Investors?
Apr 09Dechra Pharmaceuticals (LON:DPH) Has A Pretty Healthy Balance Sheet
Mar 05Are Dechra Pharmaceuticals' (LON:DPH) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 17
Dechra Pharmaceuticals PLC (LON:DPH) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
Feb 02Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: DPH 'nin kısa vadeli varlıkları ( £467.9M ) kısa vadeli yükümlülüklerini ( £164.0M ) aşıyor.
Uzun Vadeli Yükümlülükler: DPH 'un kısa vadeli varlıkları ( £467.9M ) uzun vadeli yükümlülüklerini ( £650.2M ) karşılamamaktadır.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: DPH 'nin net borç/öz sermaye oranı ( 54.7% ) yüksek olarak değerlendiriliyor.
Borcun Azaltılması: DPH şirketinin borç/öz sermaye oranı son 5 yılda 57.6% seviyesinden 64.6% seviyesine yükseldi.
Borç Kapsamı: DPH 'nin borcu işletme nakit akışı ( 13% ) tarafından iyi bir şekilde karşılanmıyor.
Faiz Kapsamı: DPH 'in borcuna ilişkin faiz ödemeleri EBIT ( 0.8 x kapsam) tarafından iyi karşılanmıyor.